Thromboxane receptor antagonists and endotoxaemia

Comment

D P Mikhailidis et al. Eicosanoids. 1989.

. 1989;2(1):59, 61-2.

No abstract available

Comment on

Effect of the thromboxane receptor antagonist, BM 13.505, on the sequelae of endotoxemia in the conscious rat.
Smith EF 3rd, Jugus M, Kinter LB. Smith EF 3rd, et al. Eicosanoids. 1988;1(1):27-33. Eicosanoids. 1988. PMID: 3078574

Thromboxane A2 and platelets as mediators of coronary arterial vasoconstriction in myocardial ischaemia.
Schrör K. Schrör K. Eur Heart J. 1990 Apr;11 Suppl B:27-34. doi: 10.1093/eurheartj/11.suppl_b.27. Eur Heart J. 1990. PMID: 2194808 Review. No abstract available.
Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits.
Robertson DN, Smith GM. Robertson DN, et al. Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:204-7. Adv Prostaglandin Thromboxane Leukot Res. 1987. PMID: 2959049 No abstract available.
[Cancer blood-borne metastasis and platelets].
Tanaka K, Fukumoto S. Tanaka K, et al. Gan To Kagaku Ryoho. 1984 Dec;11(12 Pt 1):2453-9. Gan To Kagaku Ryoho. 1984. PMID: 6391385 Japanese.
Platelets and thromboxane A2 in the pathogenesis of aging penile vascular changes and impotence.
Bornman MS, Dormehl IC, Franz RC, Du Plessis DJ, Jacobs DJ. Bornman MS, et al. Arch Androl. 1986;17(3):233-4. doi: 10.3109/01485018608990201. Arch Androl. 1986. PMID: 3606277 No abstract available.
Thromboxane and prostacyclin: implications for function and disease of the vasculature.
McGiff JC. McGiff JC. Adv Intern Med. 1980;25:199-216. Adv Intern Med. 1980. PMID: 6987841 Review. No abstract available.